Patents by Inventor Meena

Meena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF
    Publication number: 20150231141
    Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    Type: Application
    Filed: February 20, 2015
    Publication date: August 20, 2015
    Inventors: Alan S. Florjancic, Michael J. Dart, Keith B. Ryther, Arturo Perez-Medrano, William A. Carroll, Meena V. Patel, Karin Rosemarie Tietje, Tongmei Li, Teodozyj Kolasa, Megan E. Gallagher, Sridhar Peddi, Jennifer M. Frost, Derek W. Nelson
  • PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS
    Publication number: 20150224157
    Abstract: The present invention relates to novel use of the extracts of Cassia tora plant species. The present invention particularly relates to novel use of the extracts of Cassia tora leaves, which show antianxiety activity. The present invention also relates to a process for the preparation of novel herbal extract of Cassia tora species with antianxiety activity and also to the use thereof for the treatment of anxiety.
    Type: Application
    Filed: January 16, 2015
    Publication date: August 13, 2015
    Inventors: Meena R. Rathod, Bhupendra D. Shethia, Jayant B. Pandya, Prakash J. Dodiya, Gautam Palit, Manavi Chatterjee, Shibani S. Gupta, Ashok K. Agarwal, Vinay K. Khanna
  • Glucose sensor signal stability analysis
    Patent number: 9101310
    Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing an underlying trend. Other example embodiments are disclosed herein.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: August 11, 2015
    Assignee: Medtronic Minimed, Inc.
    Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
  • 6-HETEROARYLOXY- OR 6-ARYLOXY-QUINOLINE-2-CARBOXAMIDES AND METHOD OF USE
    Publication number: 20150218102
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, R2, and R3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav1.7 and/or Nav1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
    Type: Application
    Filed: February 4, 2015
    Publication date: August 6, 2015
    Inventors: Andrew Bogdan, Marlon D. Cowart, David A. DeGoey, Tammie K. Jinkerson, John R. Koenig, Michael E. Kort, Bo Liu, Mark A. Matulenko, Derek W. Nelson, Meena V. Patel, Hillary Peltier, Marc J. Scanio, Brian D. Wakefield
  • CHIRAL CONTROL
    Publication number: 20150211006
    Abstract: The present invention relates to chirally controlled oligonucleotides, chirally controlled oligonucleotide compositions, and the method of making and using the same. The invention specifically encompasses the identification of the source of certain problems with prior methodologies for preparing chiral oligonucleotides, including problems that prohibit preparation of fully chirally controlled compositions, particularly compositions comprising a plurality of oligonucleotide types. In some embodiments, the present invention provides chirally controlled oligonucleotide compositions. In some embodiments, the present invention provides methods of making chirally controlled oligonucleotides and chirally controlled oligonucleotide compositions.
    Type: Application
    Filed: July 12, 2013
    Publication date: July 30, 2015
    Inventors: David Butler, Naoki Iwamoto, Meena Meena, Nenad Svrzikapa, Gregory L. Verdine, Ivan Zlatev
  • CONTENT MANAGEMENT APPLICATION FOR AN INTERACTIVE ENVIRONMENT
    Publication number: 20150213146
    Abstract: The content management application is an intranet application which provides a process for implementing changes to an internet website of a company by providing the company the ability to define and enforce a common style of page layout. The application can be accessed via a desktop browser and multiple users may access the application for multiple reasons at the same time. The application also dynamically generates new page designs and new component design with various people assigned to groups or teams enabling the continuous creation and processing of content. Once the content is created and reviewed, it is then launched onto the company's internet site for viewing by the internet users accessing the company's web page.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Inventors: Andrea Bimson, Jin Chyung, Meena Gopakumar, Lorraine Miranda, Biswajit Sarkar, Shashikant Rao, Kaustubh Kunte
  • Method and apparatus for collaboration among individuals
    Patent number: 9088425
    Abstract: Method and systems for establishing a collaboration among individuals and an imaginary character in a virtual world are disclosed. An exemplary method may include establishing an internet protocol channel between a first individual and a program represented by the imaginary character. The exemplary method may also include establishing a non-internet protocol channel between a second individual and the program represented by the imaginary character.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: July 21, 2015
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Alok S. Raghunath Rao, Ashok K. Meena, Raju T. Ramakrishnan, Ramakrishnan R. Sankaranarayan
  • Nanostructural materials that increase mineralization in bone cells and affect gene expression through miRNA regulation and applications of same
    Patent number: 9074187
    Abstract: A method of inducing mineralization in a bone cell is described. The method comprises contacting a bone cell with a composition comprising nanoparticles. The nanoparticles can be single-walled carbon nanotubes, hydroxyapatite nanoparticles, TiO2 nanoparticles or silver nanoparticles. The bone cell can be an osteoblast cell. A method for increasing bone mass, bone healing or bone formation is also described which comprises administering to a subject in need thereof an effective amount of a composition comprising nanoparticles. The subject can suffer from a bone disease such as osteoporosis. The subject can suffer from a bone fracture and the method can comprise contacting bone cells near the bone fracture site with the composition. The composition can further comprise a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: July 7, 2015
    Assignee: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Alexandru S. Biris, Daniel Casciano, Meena Waleed Mahmood
  • Content management application for an interactive environment
    Patent number: 9015232
    Abstract: The content management application is an intranet application which provides a process for implementing changes to an internet website of a company by providing the company the ability to define and enforce a common style of page layout. The application can be accessed via a desktop browser and multiple users may access the application for multiple reasons at the same time. The application also dynamically generates new page designs and new component design with various people assigned to groups or teams enabling the continuous creation and processing of content. Once the content is created and reviewed, it is then launched onto the company's internet site for viewing by the internet users accessing the company's web page.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: April 21, 2015
    Assignee: III Holdings 1, LLC
    Inventors: Andrea Bimson, Jin Chyung, Meena Gopakumar, Lorraine Miranda, Biswajit Sarkar, Shashikant Rao, Kaustubh Kunte
  • Compounds as cannabinoid receptor ligands and uses thereof
    Patent number: 9006275
    Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: April 14, 2015
    Assignee: AbbVie Inc.
    Inventors: Alan S. Florjancic, Michael J. Dart, Keith B. Ryther, Arturo Perez-Medrano, William A. Carroll, Meena V. Patel, Karin Rosemarie Tietje, Tongmei Li, Teodozyj Kolasa, Megan E. Gallagher, Sridhar Peddi, Jennifer M. Frost, Derek W. Nelson
  • Fused tricyclic compounds as adenosine receptor antagonist
    Patent number: 9006177
    Abstract: The present disclosure relates to fused tricyclic compounds of formula (I) or its tautomers, polymorphs, stereoisomers, prodrugs, solvate or a pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by thereof as A2A adenosine receptor antagonists. The compounds of the present disclosure are useful in the treatment, prevention or suppression of diseases and disorders that may be susceptible to improvement by the mediation of adenosine A2A receptor.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: April 14, 2015
    Assignee: Advinus Therapeutics Limited
    Inventors: Dinesh Barawkar, Sujay Basu, Vidya Ramdas, Minakshi Naykodi, Meena Patel, Yogesh Shejul, Sachin Thorat, Anil Panmand
  • Substituted Fused Pyrimidine Compounds
    Publication number: 20150087643
    Abstract: The present invention discloses substituted fused pyrimidine compounds of formula (I), their tautomers, polymorphs, stereoisomers, solvates, pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by adenosine receptor (AR) activity; the compounds of the present invention are useful in the treatment, prevention or suppression of diseases and disorders that may be susceptible to improvement by antagonism of the adenosine receptor, such as asthma, chronic obstructive pulmonary disorder, angiogenesis, pulmonary fibrosis, emphysema, allergic diseases, inflammation, reperfusion injury, myocardial ischemia, atherosclerosis, hypertension, congestive heart failure, retinopathy, diabetes mellitus, obesity, inflammatory gastrointestinal tract disorders, and/or autoimmune diseases.
    Type: Application
    Filed: October 10, 2014
    Publication date: March 26, 2015
    Applicant: Advinus Therapeutics Private Limited
    Inventors: Venkata Palle, Vidya Ramdas, Dinesh Barawkar, Sujay Basu, Summon Koul, Yogesh Waman, Meena Patel, Anil Panmand
  • METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
    Publication number: 20150071917
    Abstract: The invention relates to methods and products for the identification of a clinically significant immune response in subjects treated with a therapeutic protein. A first aspect of the invention relates to methods and compositions for identifying a clinically significant immune response in patients treated with therapeutic amounts of VLA4 binding antibody (e.g., natalizumab). A second aspect of the invention concerns the chronological details of sample collection for determining the titre of antibodies against the therapeutic protein, e.g. the collection of at least two samples at two different time points. A third aspect of the invention relates to the selection of the critical threshold level, which corresponds to the antibody titre of untreated patients increased by the double of the standard deviation of this control antibody titre.
    Type: Application
    Filed: July 14, 2014
    Publication date: March 12, 2015
    Applicant: Biogen Idec MA Inc.
    Inventors: Meena Subramanyam, Lakshmi Amaravadi, Eric Wakshull, Frances Lynn, Michael Panzara, Robin McDaid Barbour, Julie Elizabeth Taylor
  • RESUMPTION OF DATA CONNECTIVITY BETWEEN MOBILE DEVICES VIA SWITCHING APPLICATION
    Publication number: 20150072662
    Abstract: The disclosure is directed to systems and methods for switching a data downloading session from a first mobile device to a second mobile device. The data downloading session first commences on the first mobile device. During the session, a download transfer condition is identified. In response, the first mobile device sends the second mobile device download resumption information, which is specifically adapted to enable the second mobile device to continue the data downloading session without having to restart an interrupted downloading operation.
    Type: Application
    Filed: September 9, 2013
    Publication date: March 12, 2015
    Applicant: NVIDIA Corporation
    Inventors: Siddarth Chandrasekaran, Rameez Syed, Mahesh Meena
  • Method and apparatus for streaming applications to a plurality of clients within a peer to-peer network
    Patent number: 8977765
    Abstract: A method and apparatus for streaming applications to a plurality of clients within a peer-to-peer network is provided. In one embodiment, a method for distributing application blocks to facilitate application streaming within a peer-to-peer network includes processing location information regarding a plurality of data chunks amongst a plurality of clients, wherein the plurality of data chunks form at least a portion of an application block and communicating the location information amongst the plurality of clients, wherein the location information is used to request at least one data chunk of the plurality of data chunks.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: March 10, 2015
    Assignee: Symantec Corporation
    Inventors: Meena Patel, Basant Rajan
  • System and method for load balancing MMEs and MME pools
    Patent number: 8948014
    Abstract: A system, method and apparatus for policy-driven load balancing of MMEs and MME pools by migrating eNodeBs service responsibilities among MMEs and/or MME processing components or modules.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: February 3, 2015
    Assignee: Alcatel Lucent
    Inventors: Murali K. Velamati, Jeffrey Furry, Joël R. Calippe, Meena Selvam
  • Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications
    Patent number: 8940751
    Abstract: The present disclosure relates to purine compounds of formula (I) or formula (II) or its tautomers, polymorphs, stereoisomers, solvates or a pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by thereof as A2B adenosine receptor antagonists. The compounds of the present disclosure are useful in the treatment, prevention or suppression of diseases and disorders that may be susceptible to improvement by the mediation of adenosine A2B receptor. The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: January 27, 2015
    Assignee: Advinus Therapeutics Private Limited
    Inventors: Dinesh Barawkar, Sujay Basu, Vidya Ramdas, Venkata Poornapragnacharyulu Palle, Yogesh Waman, Meena Patel, Anil Panmand
  • Compounds as cannabinoid receptor ligands
    Patent number: 8895592
    Abstract: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein L1, A1, R1g, z, R2, R3, and R4 are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
    Type: Grant
    Filed: December 16, 2009
    Date of Patent: November 25, 2014
    Assignee: AbbVie Inc.
    Inventors: Jennifer M. Frost, Steven P. Latshaw, Michael J. Dart, William A. Carroll, Arturo Perez-Medrano, Teodozyj Kolasa, Meena V. Patel, Derek W. Nelson, Tongmei Li, Sridhar Peddi, Xueqing Wang, Bo Liu
  • Sensing system and method for manufacturing the same
    Patent number: 8890538
    Abstract: A system includes a sensor housing having a base portion, a lid portion, and a joining portion. The joining portion is configured to be wrapped around at least a portion of an electrical wire. The lid portion includes one end detachably coupled to a first end of the base portion and another end coupled to a second end of the base portion via the joining portion. A flexible coil sensor is disposed in the sensor housing; bonded substantially along the base portion and the joining portion and configured to generate a signal representative of a fault in the electrical wire. A processing device is disposed in the sensor housing and configured to detect and locate a fault in the electrical wire in response to the signal representative of the fault in the electrical wire generated by the flexible coil sensor.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: November 18, 2014
    Assignee: General Electric Company
    Inventor: Meena Ganesh
  • METHOD OF ASSESSING RISK OF PML
    Publication number: 20140322164
    Abstract: The invention relates to methods of assessing a patient's risk of developing Progressive multifocal leukoencephalopathy (PML).
    Type: Application
    Filed: May 31, 2012
    Publication date: October 30, 2014
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Gary L. Bloomgren, Carmen Bozic, Sophia Lee, Meena Subramanyam, Tatiana Plavina